PARP10
Protein mono-ADP-ribosyltransferase PARP10
Also known as: ARTD10, FLJ14464, PAR10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53GL7
- Gene
- PARP10
- Ensembl
- ENSG00000178685
- Chromosome
- 8
- Canonical length
- 1025 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli rim,Golgi apparatus,Cytosol
OverviewNCBI Gene
Poly(ADP-ribose) polymerases (PARPs), such as PARP10, regulate gene transcription by altering chromatin organization by adding ADP-ribose to histones. PARPs can also function as transcriptional cofactors (Yu et al., 2005 [PubMed 15674325]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1025 residues, UniProt reviewed canonical sequence.
>Q53GL7|PARP10
1 MVAMAEAEAG VAVEVRGLPP AVPDELLTLY FENRRRSGGG PVLSWQRLGC GGVLTFREPA
61 DAERVLAQAD HELHGAQLSL RPAPPRAPAR LLLQGLPPGT TPQRLEQHVQ ALLRASGLPV
121 QPCCALASPR PDRALVQLPK PLSEADVRVL EEQAQNLGLE GTLVSLARVP QARAVRVVGD
181 GASVDLLLLE LYLENERRSG GGPLEDLQRL PGPLGTVASF QQWQVAERVL QQEHRLQGSE
241 LSLVPHYDIL EPEELAENTS GGDHPSTQGP RATKHALLRT GGLVTALQGA GTVTMGSGEE
301 PGQSGASLRT GPMVQGRGIM TTGSGQEPGQ SGTSLRTGPM GSLGQAEQVS SMPMGSLEHE
361 GLVSLRPVGL QEQEGPMSLG PVGSAGPVET SKGLLGQEGL VEIAMDSPEQ EGLVGPMEIT
421 MGSLEKAGPV SPGCVKLAGQ EGLVEMVLLM EPGAMRFLQL YHEDLLAGLG DVALLPLEGP
481 DMTGFRLCGA QASCQAAEEF LRSLLGSISC HVLCLEHPGS ARFLLGPEGQ HLLQGLEAQF
541 QCVFGTERLA TATLDTGLEE VDPTEALPVL PGNAHTLWTP DSTGGDQEDV SLEEVRELLA
601 TLEGLDLDGE DWLPRELEEE GPQEQPEEEV TPGHEEEEPV APSTVAPRWL EEEAALQLAL
661 HRSLEPQGQV AEQEEAAALR QALTLSLLEQ PPLEAEEPPD GGTDGKAQLV VHSAFEQDVE
721 ELDRALRAAL EVHVQEETVG PWRRTLPAEL RARLERCHGV SVALRGDCTI LRGFGAHPAR
781 AARHLVALLA GPWDQSLAFP LAASGPTLAG QTLKGPWNNL ERLAENTGEF QEVVRAFYDT
841 LDAARSSIRV VRVERVSHPL LQQQYELYRE RLLQRCERRP VEQVLYHGTT APAVPDICAH
901 GFNRSFCGRN ATVYGKGVYF ARRASLSVQD RYSPPNADGH KAVFVARVLT GDYGQGRRGL
961 RAPPLRGPGH VLLRYDSAVD CICQPSIFVI FHDTQALPTH LITCEHVPRA SPDDPSGLPG
1021 RSPDTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PARP10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- spleen: 55 nTPM
- liver: 36 nTPM
- salivary gland: 36 nTPM
- kidney: 36 nTPM
- ovary: 35 nTPM
- appendix: 34 nTPM
Single-cell type
- adipocytes: 171 nCPM
- cardiomyocytes: 153 nCPM
- early primary spermatocytes: 95 nCPM
- epicardial cells: 89 nCPM
- proximal tubule cells: 88 nCPM
- pdcs: 62 nCPM
Immune cell
- plasmacytoid DC: 17 nTPM
- gdT-cell: 4.4 nTPM
- eosinophil: 3.6 nTPM
- memory CD8 T-cell: 3.6 nTPM
- total PBMC: 3.5 nTPM
- intermediate monocyte: 2.8 nTPM
Brain region
- medulla oblongata: 32 nTPM
- spinal cord: 26 nTPM
- pons: 25 nTPM
- thalamus: 25 nTPM
- white matter: 24 nTPM
- cerebral cortex: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PARP10.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 218 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.55
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin organization
- DNA repair
- negative regulation of fibroblast proliferation
- negative regulation of gene expression
- negative regulation of NF-kappaB transcription factor activity
- negative regulation of protein K63-linked ubiquitination
- nicotinate metabolic process
- protein auto-ADP-ribosylation
- protein poly-ADP-ribosylation
- translesion synthesis
- viral protein processing
Molecular functions
- DNA-binding transcription factor binding
- K63-linked polyubiquitin modification-dependent protein binding
- NAD+ poly-ADP-ribosyltransferase activity
- NAD+-protein mono-ADP-ribosyltransferase activity
- NAD+-protein-aspartate ADP-ribosyltransferase activity
- NAD+-protein-glutamate ADP-ribosyltransferase activity
- NAD+-protein-lysine ADP-ribosyltransferase activity
- nucleotidyltransferase activity
- transcription corepressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PARP10 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PARP10 as an antibody target. Whether an autoantibody or antibody against PARP10 could matter depends on whether native PARP10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PARP10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PARP10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...